US Only

AtriCure Synergy OLL2/OSL2 clamps are approved to ablate cardiac tissue for the treatment of persistent AF or LSP AF in patients who are undergoing open concomitant CABG and/or valve replacement or repair. AtriCure Synergy Access and Synergy EMR2/EML2 clamps are cleared for cardiac tissue ablation. The AtriCure Isolator multifunctional pen and Isolator linear pen are cleared to both diagnose cardiac arrhythmias and ablate cardiac tissue. ACC2 and cryoICE BOX devices, manufactured by AtriCure, are cleared for the treatment of cardiac arrhythmias when used with cryo1 and cryoICE. The AtriClip LAA Exclusion System is indicated for the occlusion of the left atrial appendage, under direct visualization, in conjunction with other open cardiac surgical procedures.

Europe Only

AtriCure clamps are approved for the treatment of AF. The Isolator pen and Isolator Synergy Access are cleared to ablate soft tissue. The Isolator linear pen is cleared to ablate cardiac tissue and temporarily pace, sense, record, and stimulate during evaluation of cardiac arrhythmias. ACC2 and cryoICE BOX devices, manufactured by AtriCure, are cleared for the treatment of cardiac arrhythmias. The AtriClip LAA Exclusion System is used for open occlusion of the heart's left atrial appendage.

Non-European International

AtriCure clamps and Isolator pen are cleared for the ablation of soft tissue. ACC2 and cryoICE BOX devices, manufactured by AtriCure, are cleared for the treatment of cardiac arrhythmias. The AtriClip is registered in select international countries.